Ensayos clínicos de Obesidad en Florida
80 estudios sobre Obesidad buscan participantes en Florida.
Ciudades en Florida
- Orlando33 estudios
- Miami28 estudios
- Jacksonville25 estudios
- Deltona14 estudios
- Hialeah13 estudios
- Pembroke Pines10 estudios
- St. Petersburg9 estudios
- Tampa9 estudios
- The Villages9 estudios
- Ocala8 estudios
- West Palm Beach8 estudios
- Clearwater7 estudios
- Doral7 estudios
- Boca Raton7 estudios
- Davie7 estudios
- Town 'n' Country6 estudios
- Kendall6 estudios
- Tallahassee6 estudios
- Pensacola6 estudios
- Miramar5 estudios
- Hollywood5 estudios
- Leesburg4 estudios
- Spring Hill4 estudios
- Naples4 estudios
- Cape Coral3 estudios
- Palm Coast3 estudios
Texto oficial del estudio (inglés)
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Southern Clinical Research, Miami
- Research Institute of South Florida, Miami
- Clinical Neuroscience Solutions LLC, Orlando
- y 2 más
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 9 nov 2026 · NCT07871409A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Jacksonville
- Research Site, Jacksonville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Tampa Bay Medical Research, Inc., Clearwater
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
- Progressive Medical Research, Port Orange
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- Alliance for Multispecialty Research (AMR) Clinical Miami, Doral
- AMR Clinical - Fort Myers, Fort Myers
- AGA Clinical Trials, Hialeah
- y 6 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07685808Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- University of Florida Department of Medicine, Gainesville
- Aga Clinical Trials, Hialeah
- South Florida Clinical Research, Margate
- y 7 más
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07575399A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- DM Clinical Research, Bradenton
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07823608A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- Westside Center for Clinical Research, Jacksonville
- Jacksonville Center for Clinical Research, Jacksonville
- Suncoast Clinical Research, New Port Richey
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07845500Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Bioclinical Research Alliance, Miami
- Indago Research and Health Center, Miami Lakes
- Clinical Research Center Of Florida, Pompano Beach
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
- Suncoast Clinical Research, New Port Richey
- Progressive Medical Research, Port Orange
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07843498A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Clinical Research of West Florida, Inc., Clearwater
- Universal Axon Clinical Research LLC, Doral
- Westside Center for Clinical Research, Jacksonville
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07919678Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Med Research of Florida, LLC, Miami
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07854782A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Nature Coast Clinical Research, Crystal River
- West Coast Eye Institute, Lecanto
- South Broward Research, Miramar
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- American Research Centers of Florida, Pembroke Pines
- Encore Medical Research - Weston, Weston
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- NeoClinical Research, Hialeah
- Skin Care Research, Hollywood
- Encore Medical Research, Hollywood
- y 2 más
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
- All Childrens Hospital, St. Petersburg
ReclutandoFase 3
Edades de 6 a 11 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Arrow Clinical Trials, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- Fleming Island Center for Clinical Research, Fleming Island
- y 7 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- JEM Research Institute, Atlantis
- AMR Clinical, Doral
- Northeast Research Institute (NERI), Fleming Island
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Westside Center for Clinical Research, Jacksonville
- Care Access - St. Petersburg, St. Petersburg
- Conquest Research, Winter Park
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- y 3 más
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
- Emerald Coast Neurology - Airport Boulevard, Pensacola
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- y 3 más
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- International Research Associates LLC, Miami
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07915609A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
- All Childrens Hospital, St. Petersburg
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Renstar Medical Research, Ocala
- Oviedo Medical Research, Oviedo
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Omega Research Orlando, Altamonte Springs
- American Research Institute, Cutler Bay
- K2 Medical Research - Maitland, Maitland
- y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07783802Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- Fortrea Clinical Research Unit - Daytona Beach, Daytona Beach
- AGA Clinical Trials, Hialeah
- K2 Medical Research Orlando, Maitland
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Clearwater
- Research Site, Jacksonville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Orlando Heart and Vascular Institute, Altamonte Springs
- D and H Tamarac Research Center, Aventura
- Excel Medical Clinical Trials, Boca Raton
- y 18 más
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 29 oct 2026 · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Doral
- Research Site, Fleming Island
- Research Site, Fort Lauderdale
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Innovative Research of West Florida /ID# 281963, Clearwater
- Northeast Research Institute (NERI) /ID# 282015, Fleming Island
- Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
- y 10 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- DM Clinical Research, Bradenton
- DM Clinical Research, Doral
- Clinical Neuroscience Solutions, Orlando
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07837973A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight
- Ascletis Clinical Site, South Miami
ReclutandoFase 1
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07893106A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Clearwater
- ACCOMPLISH-2 Research Site, Fort Myers
- ACCOMPLISH-2 Research Site, Jacksonville
- y 5 más
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 a 79 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07654374Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Northeast Research Institute, Fleming Island
- Jacksonville Ctr For Clin Res, Jacksonville
- Center for Diab,Obes & Metab, Pembroke Pines
- y 1 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT07607587Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 50 a 95 · Todos los sexos · Actualizado el 15 oct 2026 · NCT06604650The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Imagine Research, Boynton Beach
- HCA Health Research Institute, Miami
- UMiami, Miami
- y 6 más
Reclutando
Edades de 22 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT04101669A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- Fortrea Clinical Research Unit, Daytona Beach
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07808073A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- y 2 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07589608A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
- Fortrea Clinical Research Unit, Daytona Beach
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 60 · Mujeres · Actualizado el 8 oct 2026 · NCT07808060Breathing & Blood Pressure
- Florida State University, Tallahassee
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 45 · Todos los sexos · Actualizado el 7 oct 2026 · NCT05632406De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.